Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB08884
http://purl.obolibrary.org/obo/dinto_DB08884
|
|---|---|
| Preferred Name | gadoxetate |
| Synonyms |
gadolinium(3+) ion disodium 2-({2-[bis(carboxylatomethyl)amino]-3-(4-ethoxyphenyl)propyl}({2-[bis(carboxylatomethyl)amino]ethyl})amino)acetate
C23H28GdN3Na2O11
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | gadoxetate
|
|---|---|
| label | gadoxetate
|
| DBSynonym |
shl-569b
gd-eob-dtpa
zk-139834
|
| ATCCode | V08CA10
|
| Definition | Gadoxetate is a paramagnetic gadolinium-containing contrast agent in which its salt form, gadoxetate disodium, is used for intravenous injection. Ethoxybenzyl diethylenetriaminepentaacetic acid is the moiety that chelates with a gadolinium ion and forms a stable complex with it to make up the drug. It is marketed by Bayer HealthCare Pharmaceuticals and FDA approved on July 3, 2008.
|
| DBSalt | gadoxetate disodium
|
| type | |
| InChIKey | InChIKey=SLYTULCOCGSBBJ-UHFFFAOYNA-I
|
| Synonym | gadolinium(3+) ion disodium 2-({2-[bis(carboxylatomethyl)amino]-3-(4-ethoxyphenyl)propyl}({2-[bis(carboxylatomethyl)amino]ethyl})amino)acetate
C23H28GdN3Na2O11
|
| xref |
PharmGKB:PA165985534
Drugs.com:http://www.drugs.com/mtm/gadoxetate.html
Wikipedia:http://en.wikipedia.org/wiki/Gadoxetic_acid
RxList:http://www.rxlist.com/eovist-drug.htm
National Drug Code Directory:50419-320-05
|
| CASRN | 135326-22-6
|
| prefixIRI | obo2:dinto_DB08884
|
| is transported by | |
| SMILES | [Na+].[Na+].[Gd+3].CCOC1=CC=C(CC(CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O)N(CC([O-])=O)CC([O-])=O)C=C1
|
| may interact with | |
| InChI | InChI=1/C23H33N3O11.Gd.2Na/c1-2-37-18-5-3-16(4-6-18)9-17(26(14-22(33)34)15-23(35)36)10-24(11-19(27)28)7-8-25(12-20(29)30)13-21(31)32;;;/h3-6,17H,2,7-15H2,1H3,(H,27,28)(H,29,30)(H,31,32)(H,33,34)(H,35,36);;;/q;+3;2*+1/p-5
|
| DBBrand |
eovist
primovist
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |